Deep veins thrombosis in children with blood diseases
- Authors: Zharkov P.A.1,2, Morozova D.S.3,4, Gobadze D.A.1,2, Evstratov D.A.1,2, Fedorova D.V.1,2, Zharikova L.I.1,2,5,6, Pshonkin A.V.1,2, Novichkova G.A.1,2
-
Affiliations:
- Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
- 1 Samory Mashela St., Moscow 117997
- Lomonosov Moscow State University
- 1 Leninskie Gory, Moscow 119991
- Pirogov Russian National Research Medical University, Ministry of Health of Russia
- 1 Ostrovityanova, Moscow 117997
- Issue: Vol 14, No 1 (2019)
- Pages: 20-30
- Section: HEMATOLOGIC MALIGNANCIES: TREATMENT, SUPPORTIVE CARE
- Published: 10.04.2019
- URL: https://oncohematology.abvpress.ru/ongm/article/view/332
- DOI: https://doi.org/10.17650/1818-8346-2019-14-1-20-30
- ID: 332
Cite item
Full Text
Abstract
Background. Children and adolescents undergoing treatment in the hospital for blood diseases are at risk of thrombotic complications. However, to date no major studies of the prevalence of thrombosis in this category of patients have been conducted in Russia.
The objective: to determine the incidence of symptomatic and asymptomatic deep vein thrombosis (DVT), as well as their distribution by gender and age in children with various blood disorders.
Materials and methods. Medical records of 1962 patients, aged from 0 to 17 years, were retrospectively analyzed. All DVT cases were confirmed by visualization methods. The presence of thrombosis clinical signs detected during physical examination, allowed identifying symptomatic DVT.
Results. DVT was diagnosed in 429 patients; the symptomatic (n = 110) and asymptomatic (n = 337) DVT were considered as two independent groups with cases of thrombosis. The highest incidence of thrombotic complications was found in children with acute lymphoblastic leukemia (ALL) – 30.77 %, non-Hodgkin’s lymphomas – 22.58 %, other malignant blood disorders – 18.75 %, myeloid leukemia – 15.63 %, Hodgkin’s lymphoma – 16.50 %, histiocytosis – 12.5 %, aplastic anemia – 7.94 %, other leukemia – 7.14 %. Symptomatic episodes were more common in patients with lymphomas, especially non-Hodgkin’s, and ALL, while asymptomatic DVT were more common among children with ALL.
Conclusion. The DVT prevalence in children with blood disorders exceeds 20 %, most of them are asymptomatic thrombosis, while symptomatic DVT are much less common. Patients receiving treatment for lymphomas and ALL have the highest number of venous thrombotic complications. Further research is needed to address the need for primary thrombotic prophylaxis in children with blood disorders.
Keywords
About the authors
P. A. Zharkov
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia; 1 Samory Mashela St., Moscow 117997
Author for correspondence.
Email: pavel.zharkov@fccho-moscow.ru
ORCID iD: 0000-0003-4384-6754
Russian Federation
D. S. Morozova
Lomonosov Moscow State University; 1 Leninskie Gory, Moscow 119991Russian Federation
D. A. Gobadze
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia; 1 Samory Mashela St., Moscow 117997
ORCID iD: 0000-0001-7808-1347
Russian Federation
D. A. Evstratov
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia; 1 Samory Mashela St., Moscow 117997
ORCID iD: 0000-0003-2801-7421
Russian Federation
D. V. Fedorova
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia; 1 Samory Mashela St., Moscow 117997
ORCID iD: 0000-0003-4567-1871
Russian Federation
L. I. Zharikova
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia; 1 Samory Mashela St., Moscow 117997; Pirogov Russian National Research Medical University, Ministry of Health of Russia; 1 Ostrovityanova, Moscow 117997Russian Federation
A. V. Pshonkin
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia; 1 Samory Mashela St., Moscow 117997
ORCID iD: 0000-0002-2057-2036
Russian Federation
G. A. Novichkova
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia; 1 Samory Mashela St., Moscow 117997
ORCID iD: 0000-0002-2322-5734
Russian Federation
References
Supplementary files

